جامعة المعرفة
المصدر المعتمد للمعلومات البحثية والمخرجات هو قاعدة بيانات سكوبس (Elsevier Scopus) مع تدقيق بيانات الباحثين من عمادة البحث العلمي.

Research outputs

المخرجات البحثية

مقالات ومراجعات وأوراق مؤتمرات وفصول كتب، مفهرسة برقم DOI ومربوطة بباحثي الجامعة.

78 مُخرَج نتائج البحث عن «DNA»

مراجعةوصول مفتوح20263استشهاد· Semantic Scholar

From mechanism to medicine: CRISPR‒Cas9 delivery strategies, therapeutic applications and translation challenges

Discover Nano · مجلد 21 (1)

The advent of CRISPR‒Cas technology has revolutionized genome editing by providing unprecedented precision, efficiency, and versatility in genetic manipulation. This revolutionary system originated from bacterial adaptive immunity. It allows the programmed modification of DNA sequences in a highly specific way, as long as the desired modification site contains an enzyme-compatible protospacer adjacent motif (PAM) sequence. Recent innovations with CRISPR‒Cas systems have focused on optimizing delivery methods, addressing challenges and expanding their therapeutic applications. Delivery approaches, including viral vectors, lipid nanoparticles, and other nonviral vectors, have been improved to increase target specificity while minimizing off-target effects, ensuring safe and efficient In Vivo genome editing. The applications of CRISPR‒Cas technology include the correction of genetic disorders, engineering of immune cells for cancer therapy, and combating viral infections. However, significant challenges in the form of unintended edits, immune responses, and delivery to specific tissues or organs remain formidable barriers to clinical translation. New CRISPR variants, such as base editing, prime editing, and epigenome editing, provide solutions to improve accuracy and broaden intervention. This review covers recent progress in various CRISPR delivery methodologies, discusses broadening therapeutic applications, highlights ongoing challenges, and describes the future trajectory of this disruptive technology.

CRISPR/Cas9genome editinggene deliveryviral vectors
مقالوصول مفتوح2026

Molecular Genetics of Hepatozoon canis With a Note on Effect of Parasite on the Complete Blood Count Profile of Canine Hosts

Ecology and Evolution · مجلد 16 (8) · e74039-e74039

ABSTRACT Hepatozoon canis is the causative agent of canine hepatozoonosis that results in lethargy and severe anemia during acute infection in dogs. In this investigation, 654 blood samples were collected from apparently healthy dogs in Punjab and Khyber Pakhtunkhwa (KPK) provinces in Pakistan and screened for the presence of H. canis . Phylogenetic diversity of the detected H. canis DNA, infection‐associated risk factors and parasite‐induced alterations in the host's complete blood count were also evaluated. PCR‐based screening confirmed the H. canis infection in 48 out of 654 (7.3%) dog blood samples. The presence of this apicomplexan protozoa was confirmed through Sanger sequencing. Phylogenetic reconstruction using the H. canis 18S rRNA gene showed that the sequences generated in this study clustered closely with isolates previously reported from India, Australia, Iran, Zambia, China, Spain, and Brazil. The risk factor assessment indicated that parasite prevalence differed significantly between the sampling sites but did not vary between the dog breeds, animal sex, and the presence or lack of ecto‐parasitic infestation in dogs. Reduced hematocrit levels were recorded in H. canis infected dogs. In conclusion, H. canis was prevalent among the dogs in surveyed regions of Pakistan, with infection rates varying significantly among sampling districts. Furthermore, infected dogs exhibited reduced hematocrit levels, suggesting that H. canis infection may contribute to hematological alterations even in apparently healthy animals.

Hepatozoon caniscanine hepatozoonosismolecular geneticsphylogenetic diversity
مقالوصول مفتوح2026

Vitiligo like depigmentation in a patient with NHEJ1 deficiency related radiosensitive SCID: A case report

JAAD Case Reports · مجلد 73 · 106-110

Severe combined immunodeficiency (SCID) represents a group of life-threatening primary immunodeficiencies characterized by defective T and B-lymphocyte function, typically presenting with severe and recurrent infections during early infancy.1 A subgroup of them, referred to as radiosensitive SCID, results from defects within the nonhomologous end-joining (NHEJ) pathway, which plays a crucial role in DNA double-strand break repair during V(D)J recombination. The NHEJ1 gene encodes for Cernunnos/XLF, an NHEJ1 scaffolding protein that is vital for DNA end ligation during this form of repair.

vitiligo-like depigmentationsevere combined immunodeficiencynon-homologous end joiningDNA double-strand break repair
مقالوصول مغلق2026

Effect of Polyvinyl Chloride and Polystyrene Micro‐Plastics on Growth, Digestive Enzymes, Oxidative Stress, and DNA Damage in Ctenopharyngodon idella

Journal of Applied Toxicology

Micro-plastics (MPs) have become a constant source of pollution in freshwater bodies and increasingly becoming a threat to aquatic life. Chronic exposure to MPs has been linked to the inhibition of growth, deformations in digestive physiology, oxidative stress, and cellular injury. Current study was conducted on fish (Ctenopharyngodon idella) acclimatizing and exposing them to a 90-day dietary exposure to MPs. The growth performance indicators, that is, digestive enzymes, oxidative stress biomarkers, and DNA damages were measured in the pre- and post-dietary exposure to the MPs. There was a progressive decrease in the growth performance indicators such as highest increase in weight as found in 30% PVC group (6.95 ± 2.69 g) and the 30% PS group (2.91 ± 3.28 g) was far less as compared to the corresponding controls (18.8 ± 5.86 and 16.07 ± 5.32 g, respectively). The levels of catalase activity in the control fish kidney, skin, heart, brain, and gill tissues were significantly higher than in the exposed groups (p < 0.05), whereby superoxide dismutase activity were increased, an indication to the increased oxidative stress. Digestive enzyme reactions were tissue-specific, where lipase was the most sensitive, mainly in the stomach and liver, at the increased dosage. The frequency of micronuclei also increased in the erythrocytes of exposed fish, which proves that polymers caused concentration-dependent genotoxic damage. Hence, PVC and PS MPs had negative effects on C. idella whereby growth was affected, antioxidant status was disturbed, genotoxicity was augmented, digestive enzyme biomarkers were affected, and micro-nucleus frequency was increased. Further research is required on chronic exposure, histopathological changes, and the mechanisms of MPs toxicity at the molecular level.

microplasticspolyvinyl chloridepolystyrenegrass carp
نسخة أوليةمفتوح (مستودع)2026

A Pilot Study on the Urinary Microbiome Composition and Diversity in Clinical UTI Samples: A 16S rRNA Analysis

bioRxiv (Cold Spring Harbor Laboratory)

Abstract This pilot study assessed the composition and diversity of the urinary microbiome from clinically confirmed UTI samples using 16S rRNA sequencing, whilst also exploring inter-individual variability of microbial community structure. We examined ten urine samples from patients with culture-positive UTIs. Demographic and clinical metadata, including age, sex, body mass index (BMI), diabetes status and recent antibiotic exposure was recorded per sample. Metagenomic DNA was extracted from microbial samples and sequenced to generate genus-level taxonomic profiling through 16S rRNA gene sequencing. Relative abundance tables were generated for each of the samples to identify dominant bacterial genera within each sample and summarize cohort level microbial patterns. To evaluate within-sample richness and evenness, alpha diversity indices (Shannon, Simpson, observed features and Chao1) were computed; beta diversity was measured using Bray–Curtis dissimilarity with principal coordinates analysis (PCoA) for graphical representation. The study’s findings revealed the sex and moderate clinical diversity of the study sample; all samples were confirmed as having been taken from a UTI patient and exhibited a wide level of heterogeneity regarding the microbial composition of each urine sample. Overall, Pseudomonas was the dominant genus present, however, specific samples had approximately 50% of their microbiomes composed of Klebsiella, Proteus, and Escherichia species as well as approximately 25% of their total microbes were made up of Burkholderia spp., which are closely related to the genus of interest used during the course of this study. The observed alpha diversity of each sample displayed considerable variation for the included samples with a continuum of samples ranging from a single dominant microbe to a highly diverse mixed population producing a highly diverse polymicrobial population/bacterial composition, with some ratios of individual taxa to collective taxa of many samples repeatedly illustrating the exact nature of the specimen. Furthermore, a significant degree of Beta diversity was found between the patients, providing compelling evidence of identifiable differences among urinary microbiomes between patients with UTI. This pilot project provides a clear indication of the diversity and overall heterogeneity of urinary microbiota found in the UTI patients studied. In addition, the results of this study support the notion that the ecological complexities present within a urinary microbiome cannot necessarily be established through conventional culture methods, and that combined with molecular techniques such as 16S rRNA sequencing of bacterial DNA could be used to quantify and characterize the ecologic condition of urinary microbiota separate from the traditional high prevalence of identifiable uropathogens.

urinary microbiomeurinary tract infectionbacterial diversityPseudomonas
مقالمفتوح (مستودع)2026

Nrf-2/HO-1 modulatory effects on Ocimum gratissimum flavonoid-rich leaf extract in the livers of streptozotocin-induced diabetic rats

Nutrire · مجلد 51 (1)

Abstract The present study examined the modulatory effects of Ocimum gratissimum leaf flavonoid-rich extracts on the Nrf-2 and HO-1 pathways in the livers of streptozotocin-induced diabetic rats. The animals were divided into five groups ( n = 8). These included a normal control, a diabetic control, diabetic rats administered low (LDOGFL) or high (HDOGFL) doses of Ocimum gratissimum leaf flavonoid-rich extracts at 150 and 300 mg/kg, respectively, and diabetic rats administered 200 mg/kg metformin. The animals were sacrificed on the 22nd day of the study, the liver was excised, and different biochemical parameters were evaluated. At the end of this study, diabetic rats administered LDOGFL and HDOGFL presented significant ( p < 0.05) decreases in fragmented DNA, protein carbonyl and lipid peroxidation levels, as well as glucose-6-phosphatase, and fructose 1,6 bisphosphatase activities. However, there was a significant ( p < 0.05) increase in the levels of antioxidant biomarkers; phosphatase and transaminase activities; GLUT 2 and glycogen levels; glycogen synthase and phosphorylase; hexokinase, pyruvate kinase and glucose-6-phosphate dehydrogenase activities; and serum albumin and insulin in diabetic rats treated with extracts. Furthermore, there was a substantial increase in the relative gene expression of Nrf2 and HO-1, especially in diabetic rats administered LDOGFL. Hence, these findings suggest that these extracts might be helpful in managing hepatopathy in patients with diabetes mellitus.

Ocimum gratissimumNrf2heme oxygenase-1streptozotocin-induced diabetes
مقالوصول مغلق2026

Ubiquitin in Human Diseases: Pathophysiology, Dysfunction and Treatment

Current Pharmaceutical Design · مجلد 32

Ubiquitin machinery is an essential regulatory system that maintains protein stability, degradation, and signalling by balancing ubiquitination and deubiquitination. In addition to its classical function in protein tagging for proteasomal degradation, ubiquitin has several essential cellular functions, including cell-cycle regulation, DNA repair, immunomodulation, intracellular signalling, and cellular stress responses. Abnormal regulation of this highly ordered system has been implicated in the pathogenesis of cancer, neurodegenerative diseases, infectious diseases, metabolic dysfunction, and autoimmunity. Recent developments in structural biology, chemical biology, and proteomics have increased our understanding of ubiquitin signalling and identified new therapeutic targets by revealing context-specific interactions within nodes of the ubiquitinproteasome system. Future approaches to restore proteostasis involve selective inactivation of proteasomal subunits, E3 ligases, and deubiquitinating enzymes (DUBs), as well as novel modalities such as proteolysistargeting chimeras (PROTACs) and molecular glues that redirect ubiquitin-dependent degradation of diseaserelevant proteins. Although preclinical and early clinical studies have demonstrated target specificity, longterm safety remains a challenge for clinical translation. This review provides an overview of ubiquitin's pathophysiological functions in key human diseases, therapeutic interventions, and the potential of ubiquitin-based therapeutic strategies for precision medicine and targeted drug therapy.

ubiquitinubiquitin-proteasome systemubiquitinationdeubiquitination
مراجعةمفتوح (مستودع)202534استشهاد· Semantic Scholar

A Comprehensive Review on the Molecular Mechanism of Lycopene in Cancer Therapy

Food Science & Nutrition · مجلد 13 (7) · e70608-e70608

The continuous progression of cancerous severity due to the interaction of physical (ultraviolet radiation), chemical (smoking, mycotoxins, and heavy metals), and biological (microbial populations) carcinogens inspired scientists to develop a correlation between active therapeutic agents and cancer proliferation. This review highlights the molecular mechanism by which lycopene imparts its anticancerous role, focusing on clinical and animal trials to validate its effectiveness. The antioxidant profile of lycopene promotes anticancerous properties that reduce cancer prevalence by activating cell signaling pathways and gene expression (involved in cancer cell proliferation). Lycopene's anti-inflammatory properties suppresses the tumor growth and development-promoting pathways, such as the PI3K/Akt/mTOR pathway. The anticancer property of lycopene is also evidenced by its inhibitory potential of the Wnt/β-catenin signaling pathway that is involved in cancer cell modulation and propagation. Lycopene also suppresses and neutralizes oxidative stress and reactive oxygen species (ROS)-induced DNA damage, preventing gene mutation. Inflammation-induced cell death is mitigated by lycopene's anti-inflammatory potential that lowers the expression of interleukin 6 (IL-6) and tumor necrosis factor-alpha (TNF-α). Several clinical and randomized control trials have revealed the effect of lycopene supplementation in the management of cancer, including breast cancer, pancreatic cancer, prostate cancer, colon cancer, ovarian cancer, skin cancer, oral cancer, liver cancer, gastric cancer, and kidney cancer, by lessening prostate-specific antigen (PSA) levels. These studies also accentuate certain limitations that need further trials to evaluate the long-term consequences of lycopene supplementations and their specific effective dose.

lycopeneanticancer activitymolecular mechanismsantioxidants
مقالوصول مفتوح202532استشهاد· Semantic Scholar

Multi-scale feature fusion of deep convolutional neural networks on cancerous tumor detection and classification using biomedical images

Scientific Reports · مجلد 15 (1) · 1105-1105

In the present scenario, cancerous tumours are common in humans due to major changes in nearby environments. Skin cancer is a considerable disease detected among people. This cancer is the uncontrolled evolution of atypical skin cells. It occurs when DNA injury to skin cells, or a genetic defect, leads to an increase quickly and establishes malignant tumors. However, in rare instances, many types of skin cancer occur from DNA changes tempted by infrared light affecting skin cells. This disease is a worldwide health problem, so an accurate and appropriate diagnosis is needed for efficient treatment. Current developments in medical technology, like smart recognition and analysis utilizing machine learning (ML) and deep learning (DL) techniques, have transformed the analysis and treatment of these conditions. These approaches will be highly effective for the recognition of skin cancer utilizing biomedical imaging. This study develops a Multi-scale Feature Fusion of Deep Convolutional Neural Networks on Cancerous Tumor Detection and Classification (MFFDCNN-CTDC) model. The main aim of the MFFDCNN-CTDC model is to detect and classify cancerous tumours using biomedical imaging. To eliminate unwanted noise, the MFFDCNN-CTDC method initially utilizes a sobel filter (SF) for the image preprocessing stage. For the segmentation process, Unet3+ is employed, providing precise localization of tumour regions. Next, the MFFDCNN-CTDC model incorporates multi-scale feature fusion by combining ResNet50 and EfficientNet architectures, capitalizing on their complementary strengths in feature extraction from varying depths and scales of the input images. The convolutional autoencoder (CAE) model is utilized for the classification method. Finally, the parameter tuning process is performed through a hybrid fireworks whale optimization algorithm (FWWOA) to enhance the classification performance of the CAE model. A wide range of experiments is performed to authorize the performance of the MFFDCNN-CTDC approach. The experimental validation of the MFFDCNN-CTDC approach exhibited a superior accuracy value of 98.78% and 99.02% over existing techniques under ISIC 2017 and HAM10000 datasets.

skin cancer detectionskin lesion classificationmulti-scale feature fusionconvolutional neural networks
مراجعةمفتوح (مستودع)202523استشهاد· Semantic Scholar

Anticancer Molecular Mechanisms of Epigallocatechin Gallate: An Updated Review on Clinical Trials

Food Science & Nutrition · مجلد 13 (8) · e70735-e70735

Human physiology is a complex process encompassing various biochemical mechanisms, regulated by hundreds of chemical mediators, thus making it more complicated to understand. Balance between these mediators is mandatory to continue the helm of life; however, an imbalance can disrupt normal physiological functions and lead to chronic health conditions. Cancer is one such chronic state that occurs due to an imbalance or overproduction of reactive oxygen and nitrogen species (RONS), which are highly unstable and damage other chemical constituents in the body. The mutilation at the cellular level results in DNA and genetic mutation, uncontrolled cell proliferation, metastasis, organ dysfunction, and ultimately mortality. Various types of cancers are intimidating human life globally, and lung cancer is leading them all, followed by breast and colorectal cancer. Oxidative stress (OS) is the main root cause of cancers that occur due to overproduced RONS. Tumor suppressor genes (TSGs) like p53, PTEN, INK4, MADR2, APC, and oncogenes such as HER2, BCR/ABL1, CMYC, EML4AK, RAS, WNT, ERK, and TRK get mutated by OS. Moreover, various pro-inflammatory markers i.e., IL-1, IL-6, TNF-α, IFN-γ, TGF-β and growth factors (VEGF, EGF, IGF-2) are also involved in cancer progression. Along with these aspects, the oncogenesis involves different signaling pathways/axis such as MAPK, PI3K, mTOR, Wnt/β-catenin, GSK3, and NF-κB. Epigallocatechin gallate (EGCG), a bioactive compound abundantly existing in green tea and grapes with strong antioxidant activity and anticancer potential, is a suitable approach to reduce the cancer burden. The in vitro and in vivo anticancer studies of EGCG proved anticancer and anti-tumor effects through modulation of cancer signaling pathways, reduction in cell proliferation, decreased metastasis, suppressed angiogenesis, enhanced antioxidant activity, inhibited pro-inflammatory biomarkers, improved TSGs expression, and downregulated oncogenes expression. Shortly, the current review focuses on the anticancer potential of EGCG through possible mechanisms.

epigallocatechin gallategreen teaanticancer mechanismoxidative stress
مراجعةوصول مفتوح202523استشهاد· Semantic Scholar

Pivotal role of Helicobacter pylori virulence genes in pathogenicity and vaccine development

Frontiers in Medicine · مجلد 11 · 1523991-1523991

One of the most prevalent human infections is Helicobacter pylori (H. pylori), which affects more than half of the global population. Although H. pylori infections are widespread, only a minority of individuals develop severe gastroduodenal disorders. The global resistance of H. pylori to antibiotics has reached concerning levels, significantly impacting the effectiveness of treatment. Consequently, the development of vaccines targeting virulence factors may present a viable alternative for the treatment and prevention of H. pylori infections. This review aims to provide a comprehensive overview of the current understanding of H. pylori infection, with a particular focus on its virulence factors, pathophysiology, and vaccination strategies. This review discusses various virulence factors associated with H. pylori, such as cytotoxin-associated gene A (cagA), vacuolating cytotoxin gene (vacA), outer membrane proteins (OMPs), neutrophil-activated protein (NAP), urease (ure), and catalase. The development of vaccines based on these virulence characteristics is essential for controlling infection and ensuring long-lasting protection. Various vaccination strategies and formulations have been tested in animal models; however, their effectiveness and reproducibility in humans remain uncertain. Different types of vaccines, including vector-based vaccines, inactivated whole cells, genetically modified protein-based subunits, and multiepitope nucleic acid (DNA) vaccines, have been explored. While some vaccines have demonstrated promising results in murine models, only a limited number have been successfully tested in humans. This article provides a thorough evaluation of recent research on H. pylori virulence genes and vaccination methods, offering valuable insights for future strategies to address this global health challenge.

Helicobacter pylorivirulence factorsvaccine developmentCagA
مراجعةمفتوح (مستودع)202517استشهاد· Semantic Scholar

Eugenol: An Insight Into the Anticancer Perspective and Pharmacological Aspects

Food Science & Nutrition · مجلد 13 (8) · e70727-e70727

The aura of the 21st century has been transformed due to a revolutionized health care system and modern industrial applications. However, human health and well-being are still a global challenge, affected by various metabolic and pathological morbidities, causing millions of mortalities. Cancer is one of the leading causes of fatalities globally, occurring due to pathogens, dietary factors, environmental toxins, occupational chemical exposure, and radiation. These factors lead to oxidative stress (OS), inflammation, DNA damage, epigenetic and genetic mutations, cell proliferation, tumorigenesis, and other chronic metabolic disorders such as diabetes mellitus, cardiovascular disorders, gastrointestinal problems, and hepato-renal syndrome. Among various types of cancers, lung cancer is leading them all, followed by breast and colorectal cancer (CRC). The oncogenesis includes activation of pro-inflammatory markers (IL-6, IL-1β, TNF-α), resulting in overexpression of oncogenes, downregulation of tumor suppressor genes (TSGs) like p53, pRb, APC, PTEN, suppression of antioxidant enzymes (GSH, CAT, SOD), and activation of signaling pathways (PI3K/Akt/mTOR/NF-κB, Ras/MAPK). However, plant-based herbal medicine is a valuable, affordable, and available management approach to reduce the risks of oncogenesis and other ailments. The bioactive compounds of these herbs make them an effective way to reduce inflammation, cancer, and the risk of other health problems. Eugenol (Eug), a volatile phenolic bioactive compound with a formula of C10H12O2, has been reported to have anticancer, antidiabetic, cardio- and pulmonary protective roles. Moreover, it can improve gut health and prevent neurodegenerative disorders. According to WHO, the safe dose of eugenol is 2.5 mg/kg for consumption. The current review focuses on the anticancer potential and other pharmacological aspects of eugenol through possible mechanisms.

eugenolanticancer activityoxidative stressinflammation
مقالوصول مفتوح202511استشهاد· Semantic Scholar

Aotaphenazine, a rare hydrophenazine, targets topoisomerase II with anticancer efficacy: In silico to in vitro evidence

PLoS ONE · مجلد 20 (12) · e0338135-e0338135

BACKGROUND: Topoisomerase II (Topo II) remains a validated target for anticancer therapy, with many clinically used agents acting via DNA intercalation and enzyme inhibition. However, their clinical use is limited by severe toxicity and resistance. In this study, we investigate aotaphenazine, a rare hydrophenazine derivative isolated from Streptomyces sp. IFM 11694 as a potential novel Topo II inhibitor with selective anticancer activity. METHODS: Molecular docking and 400 ns molecular dynamics (MD) simulations were employed to evaluate aotaphenazine's binding mode within the DNA-Topo II complex (PDB: 3QX3). MM-GBSA calculations quantified interaction energetics, while ProLIF and PLIP analyses detailed the interaction patterns. Topo II inhibition was assessed via in vitro enzymatic assays. Cytotoxicity (MTT) assays were conducted against a panel of human cancer and normal cell lines. Flow cytometry was used to evaluate apoptosis and cell cycle progression in MDA-MB-231 cells. RESULTS: aotaphenazine demonstrated a docking binding energy of -19.12 kcal/mol and remained stably intercalated within the DNA groove during MD simulations. MM-GBSA analysis showed a total binding free energy of -29.81 kcal/mol, driven primarily by van der Waals forces. Interaction profiling identified consistent π-stacking with Cyt8 and Thy9, and strong binding contributions from Ade12 and Gua13. Enzymatic assays confirmed Topo II inhibition with an IC50 of 45.01 nM, comparable to doxorubicin (30.16 nM). In vitro cytotoxicity analysis revealed moderate activity across cancer cell lines (IC50 = 26.30-54.35 µM) and significantly reduced toxicity in normal WI-38 and WISH cells (IC50 = 69.86 µM and 84.72 µM, respectively). Flow cytometry showed that aotaphenazine induced early (20.98%) and late apoptosis (42.80%), along with S-phase cell cycle arrest (43.99%) and a marked reduction in the G2/M population in MDA-MB-231 cells. CONCLUSION: aotaphenazine exhibits a compelling combination of Topo II inhibition, DNA intercalation, and selective anticancer activity, supported by both computational modeling and biological validation. Its lower cytotoxicity toward normal cells and ability to induce apoptosis and cell cycle arrest suggest strong therapeutic potential. These findings establish aotaphenazine as a promising lead compound for the development of safer and more selective Topo II-targeting anticancer agents.

topoisomerase II inhibitionDNA intercalationanticancer activitynatural product isolation